Elucidating the need for prostate cancer risk calculators in conjunction with mpMRI in initial risk assessment before prostate biopsy at a tertiary prostate cancer center

Abstract Objective Utilizing personalized risk assessment for clinically significant prostate cancer (csPCa) incorporating multiparametric magnetic resonance imaging (mpMRI) reduces biopsies and overdiagnosis. We validated both multi- and univariate risk models in biopsy-naïve men, with and without...

Olles dieđut

Bibliográfalaš dieđut

Váldodahkkit:	Philipp Krausewitz, Thomas Büttner, Marthe von Danwitz, Richard Weiten, Alexander Cox, Niklas Klümper, Johannes Stein, Julian Luetkens, Glen Kristiansen, Manuel Ritter, Jörg Ellinger
Materiálatiipa:	Artigo
Giella:	Inglês
Almmustuhtton:	BMC 2024-03-01
Ráidu:	BMC Urology
Fáttát:	Clinically significant prostate cancer Prostate biopsy mpMRI Risk calculators
Liŋkkat:	https://doi.org/10.1186/s12894-024-01460-5
Fáddágilkorat:	Lasit fáddágilkoriid Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!